Peace in strength.  Like the mighty oak that has survived some 600 years in what is now my back yard, we engage with experience and resilience.  Whether the winds blow hard or the sun shines bright, we go on, deeply rooted and stretching for the heavens.

Strength in peace.  Many challenges of the world, and Pharmaceutical R&D, grow out of mere misunderstandings.  We seek to enhance mutual understanding and peaceful cooperation toward shared objectives.

- Peace and Strength by Kevin Freiert

Fellow Travelers on a Long, Cold Road

By Kevin Freiert | October 2, 2017 |

The journey to a new medicine is a challenging, uphill, and winding road. Whenever a patient gets involved in medicines development, they are likely to face a roller coaster of hopefulness and despair like they have never experienced. Since only about 5% of the compounds and proteins put into advanced testing a…

Read More

Leveling the Playing Field

By Kevin Freiert | September 25, 2017 |

“A champion named Goliath…came out from the Philistine camp. He was over nine feet tall. He had a bronze helmet on his head and wore a coat of scale armor of bronze weighing [125 pounds]; on his legs he wore bronze greaves, and a bronze javelin was slung on his back. His…

Read More

The Language of Drug Development

By Kevin Freiert | September 18, 2017 |

Let’s do a quick word association exercise. What is the first word that comes to mind when you read each of the terms below? Trial Investigator Subject Attrition Arms Targets Chances are your responses were somehow affected by your level of familiarity with medicines development. Introduction Patients are the most important…

Read More

It is Time to Equip Patients to Shape Drug Development

By Kevin Freiert | September 11, 2017 |

Introduction Patients are the most important stakeholders in the development of new therapies. Thus, one might conclude that patients must be involved in the process of developing these therapies. While there are some excellent examples of patient involvement improving both the execution and the focus of clinical trials, it is far from the…

Read More